Cargando…

SorCS3 promotes the internalization of p75(NTR) to inhibit GBM progression

Glioblastoma (GBM) is a fatal malignancy caused by dysregulation of cellular signal transduction. Internalization plays a key role in maintaining signalling balance. Previous reports showed that Sortilin related VPS10 domain containing receptor 3 (SorCS3) has the ability to regulate internalization....

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yanqiu, Li, Yue, Fan, Yuhua, Zhang, Xiaoyuan, Tang, Zhihong, Qi, Jing, Zhao, Baoshan, Li, Fuyuan, Chen, Xiaofeng, Liang, Huan, Xu, Haiyan, Li, Dongliang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8989992/
https://www.ncbi.nlm.nih.gov/pubmed/35393432
http://dx.doi.org/10.1038/s41419-022-04753-5
Descripción
Sumario:Glioblastoma (GBM) is a fatal malignancy caused by dysregulation of cellular signal transduction. Internalization plays a key role in maintaining signalling balance. Previous reports showed that Sortilin related VPS10 domain containing receptor 3 (SorCS3) has the ability to regulate internalization. However, the impacts of SorCS3 on the biological processes involved in GBM have not yet been reported. In this study, we investigated the bio-function of SorCS3 in GBM. We found that SorCS3 was significantly downregulated in GBM. In addition, low expression level of SorCS3 predicted poor prognoses in patients with GBM. Here, we proved that SorCS3 suppressed cell invasion and proliferation mainly via NGF/p75(NTR) pathway in GBM. We found that SorCS3 co-localized with p75(NTR) in GBM cells and regulated the p75(NTR) protein level by promoting trafficking of the endosomal to the lysosome. Immunofluorescence (IF) and Co-Immunoprecipitation (Co-IP) detection confirmed that SorCS3 bound to p75(NTR), which subsequently increased the internalization of p75(NTR), and then transported p75(NTR) to the lysosome for degradation, ultimately contributing to inhibit of glioma progression. Taken together, our work suggests that SorCS3 is a marker of promising prognosis in GBM patients and suggests that SorCS3 regulates internalization, which plays a pivotal role in inhibiting glioma progression.